Sexual activity and function among middle-aged and older men and women with hypertension

被引:38
作者
Spatz, Erica S. [1 ]
Canavan, Maureen E. [2 ]
Desai, Mayur M. [3 ]
Krumholz, Harlan M. [4 ,5 ,6 ]
Lindau, Stacy T. [7 ,8 ,9 ,10 ]
机构
[1] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06520 USA
[3] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA
[4] Yale Univ, Sch Med, Robert Wood Johnson Fdn Clin Scholars Program, New Haven, CT 06520 USA
[5] Yale Univ, Sch Med, Dept Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
[6] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA
[7] Univ Chicago, Dept Obstet & Gynecol, Chicago, IL 60637 USA
[8] Univ Chicago, Dept Geriatr Med, Chicago, IL 60637 USA
[9] Univ Chicago, Ctr Demog & Econ Aging, Chicago Core Biomeasures Populat Based Aging Res, Chicago, IL 60637 USA
[10] Univ Chicago, NORC, Chicago, IL 60637 USA
基金
美国国家卫生研究院;
关键词
antihypertensive medication; elderly; hypertension; quality of life; sexual function; sexual health; QUALITY-OF-LIFE; ERECTILE DYSFUNCTION; ANTIHYPERTENSIVE DRUGS; PREVALENCE; THERAPY; HEALTH; ADULTS; BEHAVIOR; SYMPTOMS; EVENTS;
D O I
10.1097/HJH.0b013e32835fdefa
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: To determine the association of hypertension (HTN) and its treatment with sexual function in middle-aged and older adults. Methods: We studied a nationally representative sample of community-residing adults aged 57-85 years (n = 3005) from the National Social Health, Life and Aging Project. Adults were categorized by HTN status (treated, untreated, and no HTN). Antihypertensive medication use was classified into calcium channel blocker; beta-blocker; angiotensin-converting enzyme inhibitor/angiotensin receptor blocker; diuretic; and a-blocker. For each HTN and medication group, we determined the prevalence and adjusted odds of being sexually active and of having any sexual problem. Results: Among men, comparing treated HTN with untreated HTN and no HTN, sexual activity was less prevalent (66.5 vs. 75.9 vs. 71.5%, P<0.01) and sexual problems were more prevalent (69.1 vs. 57.7 vs. 54.3%; P <= 0.01). There was no association between treated HTN and sexual activity [odds ratio, OR = 0.86 (95% confidence interval 0.51-1.45)] and a nonsignificant association between treated HTN and sexual problems [OR = 1.49 (0.94-2.37)]. Among women, the prevalence of sexual activity was lower in the treated and untreated HTN groups than the no HTN group (35.2 vs. 38.3 vs. 58.0%, P<0.01); the prevalence of sexual problems was similar (73.7 vs. 65.3 vs. 71.7%; P = 0.301). Women in the treated HTN [OR = 0.61 (0.39-0.95)] and untreated HTN [0.54 (0.30-0.96)] groups had a lower odds of sexual activity compared with no HTN. There were no significant associations between antihypertensive medication class and sexual activity or problems in men or women. Conclusion: The relationship between HTN and sexual health is different for older men and women. Prospective, comparative effectiveness trials are needed.
引用
收藏
页码:1096 / 1105
页数:10
相关论文
共 47 条
[1]   Sexual activity and function in postmenopausal women with heart disease [J].
Addis, RB ;
Ireland, CC ;
Vittinghoff, E ;
Lin, T ;
Stuenkel, CA ;
Hulley, S .
OBSTETRICS AND GYNECOLOGY, 2005, 106 (01) :121-127
[2]   What you see may not be what you get: A brief, nontechnical introduction to overfitting in regression-type models [J].
Babyak, MA .
PSYCHOSOMATIC MEDICINE, 2004, 66 (03) :411-421
[3]   Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome [J].
Baumhaekel, M. ;
Schlimmer, N. ;
Boehm, M. .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (05) :493-500
[4]   Erectile Dysfunction Predicts Cardiovascular Events in High-Risk Patients Receiving Telmisartan, Ramipril, or Both The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (ONTARGET/TRANSCEND) Trials [J].
Boehm, Michael ;
Baumhaekel, Magnus ;
Teo, Koon ;
Sleight, Peter ;
Probstfield, Jeffrey ;
Gao, Peggy ;
Mann, Johannes F. ;
Diaz, Rafael ;
Dagenais, Gilles R. ;
Jennings, Garry L. R. ;
Liu, Lisheng ;
Jansky, Petr ;
Yusuf, Salim .
CIRCULATION, 2010, 121 (12) :1439-U114
[5]   Sexual dysfunction in the elderly: age or disease? [J].
Camacho, ME ;
Reyes-Ortiz, CA .
INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2005, 17 (Suppl 1) :S52-S56
[6]   THE IMPACT OF DIURETIC THERAPY ON REPORTED SEXUAL FUNCTION [J].
CHANG, SW ;
FINE, R ;
SIEGEL, D ;
CHESNEY, M ;
BLACK, D ;
HULLEY, SB .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (12) :2402-2408
[7]   Erectile Dysfunction after Therapy with Metoprolol: The Hawthorne Effect [J].
Cocco, G. .
CARDIOLOGY, 2009, 112 (03) :174-177
[8]   SEXUAL SYMPTOMS IN HYPERTENSIVE PATIENTS - A CLINICAL-TRIAL OF ANTIHYPERTENSIVE MEDICATIONS [J].
CROOG, SH ;
LEVINE, S ;
SUDILOVSKY, A ;
BAUME, RM ;
CLIVE, J .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (04) :788-794
[9]   LONG-TERM SURVEILLANCE FOR ADVERSE-EFFECTS OF ANTIHYPERTENSIVE DRUGS [J].
CURB, JD ;
BORHANI, NO ;
BLASZKOWSKI, TP ;
ZIMBALDI, N ;
FOTIU, S ;
WILLIAMS, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1985, 253 (22) :3263-3268
[10]   Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects [J].
Doumas, M ;
Tsakiris, A ;
Douma, S ;
Grigorakis, A ;
Papadopoulos, A ;
Hounta, A ;
Tsiodras, S ;
Dimitriou, D ;
Giamarellou, H .
JOURNAL OF ANDROLOGY, 2006, 27 (03) :469-477